News for Ainos, Inc. (AIMD)

Robotic smelltech by AI Nose moves from concept to integration in weeksPartnership fast-tracks robotic smell integration as global service robotics market nears

Ainos (NASDAQ: AIMD) successfully integrates AI Nose technology into a humanoid robot by ugo, marking a global first in robotic smell detection. Software in

Ainos, Inc. (AIMD) has made a significant advancement in robotics by installing its proprietary AINose olfaction module on a humanoid robot developed in collabo

Ainos (AIMD) and ugo have achieved the world's first installation of a functional smell module in a humanoid robot, completed on April 9, 2025. The AI N

Dual Trials Accelerate VELDONA® Toward Rare Disease Market EntryBridging Strategy Aims to Fast-Track U.S. Regulatory Approvals SAN DIEGO, CALIFORNIA / ACCESS N

Ainos (AIMD) has received TFDA approval for an HIV oral warts clinical trial and IRB clearance for a Sjögren's Syndrome study in Taiwan. The HIV oral w

Strategic partnerships and industry-leading accuracy position Ainos as a game-changer in digitized scent technology SAN DIEGO, CALIFORNIA / ACCESS Newswire / Ap

Ainos (AIMD) is expanding its AI Nose technology into robotics and semiconductor manufacturing, targeting a multi-billion-dollar market. The technology

SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 24, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digi

Unveiled revolutionary AI Nose for robotics application, inviting global robotics companies to join Ainos Alliance in shaping the future of smell-enabled robots

Revolutionary Oral Interferon Technology Combines Unmatched Advantages and Global Potential in the $16 Billion Coronavirus Market SAN DIEGO, CA / ACCESS Newswir

Report highlights greater visibility in AI Nose developments, including robotics, smart manufacturing, elderly care monitoring, and women's health testing SAN D

SAN DIEGO, CA / ACCESSWIRE / December 13, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on

SAN DIEGO, CA / ACCESSWIRE / December 4, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on

AIMD Stock Hits 52-Week Low at $0.4 Amid Market Challenges

Cutera Inc. (CUTR) experienced a significant stock price decline of 5.14%, bringing its price to $0.751 per share. The trading volume reached 26,733 shares, wit

AIMD stock touches 52-week low at $0.45 amid market challenges

Ainos set for clinical trial of HIV treatment at Taiwan hospital

Ainos AI Nose achieves 79% accuracy in VOC detection